Skip to content

Change in AR at other companies

Gilead Sciences logo
Gilead SciencesGILD
-$134M-69.6%
Arrowhead Research logo
Arrowhead ResearchARWR
$212.05M+8,382%
TG Therapeutics logo
TG TherapeuticsTGTX
$86.42M+41.8%
BridgeBio Pharma logo
BridgeBio PharmaBBIO
$65.78M-40.5%
Rhythm Pharmaceuticals, Inc. logo
Rhythm Pharmaceuticals, Inc.RYTM
ALN
Alnylam PharmaceuticalsALNY

Other financials

Income statement

See full
Revenue$159.9M+43.3%
Operating income-$789.5M-5,100%
Net income-$790.2M-5,284%
EPS (diluted)-$13.43-4,377%

Balance sheet

See full
Cash & equivalents$261.5M+43.5%
Total debt$13.5M+56.4%
Total equity$242.5M+4.0%
Total assets$890.9M+29.1%

Cash flow

See full
Operating cash flow-$228.8M-11,566%
CapEx$664.0K+1,520%
Free cash flow-$229.4M-11,360%

Valuation

See full
Market cap$6.53B+152%
Enterprise value$6.28B+162%
P/S11.5×+4.6×

Profitability

See full
Operating margin-139.8%-168pp
Net margin-140.2%-169pp
FCF margin-30.3%

Returns & leverage

See full
Return on equity-335.8%-377pp
Debt / equity0.1×0.0×
Current ratio2.1×-1.1×

Where this comes from

Reported directly by Mirum Pharmaceuticals, Inc. in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsReceivable.

The official record: Mirum Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Mirum Pharmaceuticals, Inc.'s change in ar.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Mirum Pharmaceuticals, Inc.'s change in AR?
Mirum Pharmaceuticals, Inc. (MIRM) reported change in AR of $12.89M in Q1 2026.
How has Mirum Pharmaceuticals, Inc.'s change in AR changed year-over-year?
Mirum Pharmaceuticals, Inc.'s change in AR decreased by 23.4% year-over-year, from $16.83M to $12.89M.
What does change in AR mean?
Increase or decrease in amounts owed by customers — the primary working capital driver for many businesses.